Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal etanercept for active discoid lupus erythematosus
2015-001602-33Phase 2Completed
- Sponsor
- University of Leeds
- Start
- Sep 2015
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of etanercept in discoid lupus erythematosus (DLE), sponsored by University of Leeds. Primary endpoint: Clinical response in index lesion at Week 12. Started Sep 2015; status: completed.
02
Drugs
etanercept
03
Conditions
discoid lupus erythematosus (DLE)
Beyond the preview
Go deeper on 2015-001602-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001602-33.